Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability

Cited by (1,003)

Items 701–800 of 1,003

1. Advancing mRNA technologies for therapies and vaccines: An African context
   Kairuz, Dylan, Samudh, Nazia, Ely, Abdullah, Arbuthnot, Patrick, Bloom, Kristie · 2022 · Frontiers in Immunology
2. Recent Advancements in mRNA Vaccines: From Target Selection to Delivery Systems
   Zhongyan Wu, Weilu Sun, Hailong Qi · 2024 · Vaccines
3. Molecular targets and strategies in the development of nucleic acid cancer vaccines: from shared to personalized antigens
   Wei-Yu Chi, Yingying Hu, Hsin‐Che Huang, Hui–Hsuan Kuo, Shu‐Hong Lin, Chun-Tien Jimmy Kuo, Julia Tao, Darrell Fan, Yi-Min Huang, Annie A. Wu et al. · 2024 · Journal of Biomedical Science
4. Quantitative profiling of human translation initiation reveals elements that potently regulate endogenous and therapeutically modified mRNAs
   Lewis, Cole J.T., Xie, Li H., Bhandarkar, Shivani Milind, Jin, Danni, Abdallah, Kyrillos, Draycott, Austin S., Chen, Yixuan, Thoreen, Carson C., Gilbert, Wendy V. · 2025 · Molecular Cell
5. Clinical advancements in mRNA vaccines against viral infections
   Munazza Tamkeen Fatima, Pil‐Gu Park, Kee‐Jong Hong · 2024 · Clinical Immunology
6. Mannich reaction-based combinatorial libraries identify antioxidant ionizable lipids for mRNA delivery with reduced immunogenicity
   Ningqiang Gong, Dongyoon Kim, Mohamad‐Gabriel Alameh, Rakan D. El-Mayta, Emily Laura Han, Garima Dwivedi, Rohan Palanki, Qiangqiang Shi, Xuexiang Han, Lulu Xue et al. · 2025 · Nature Biomedical Engineering
7. Transient hepatic reconstitution of trophic factors enhances aged immunity
   Mirco Friedrich, Julie Pham, Jiakun Tian, Hongyu Chen, Jiahao Huang, Niklas Kehl, Sophia Liu, Blake Lash, Fei Chen, Xiao Wang et al. · 2025 · Nature
8. A New Generation of Vaccines in the Age of Immunotherapy
   Alfredo Addeo, Alex Friedlaender, Elisa Giovannetti, Alessandro Russo, Diego de Miguel‐Pérez, Oscar G. Arrieta, Andrés Felipe Cardona, Christian D. Rolfo · 2021 · Current Oncology Reports
9. Recent Advances in the Molecular Design and Delivery Technology of mRNA for Vaccination Against Infectious Diseases
   Yang Lü, Lin Tang, Ming Zhang, Chaoyong Liu · 2022 · Frontiers in Immunology
10. Vaccines against SARS-CoV-2 variants and future pandemics
    Taeyoung Park, Hyogyeong Hwang, Suhyeong Moon, Sang Gu Kang, Seunghyup Song, Young Hun Kim, Hanbi Kim, Eun‐Ju Ko, Soon‐Do Yoon, Sang‐Moo Kang et al. · 2022 · Expert Review of Vaccines
11. Nucleic acid–protein condensates in innate immune signaling
    Giulia Ada Corbet, James M. Burke, Roy Parker · 2022 · The EMBO Journal
12. Safe and Effective Delivery of mRNA Using Modified PEI-Based Lipopolymers
    Huijing Wang, Xin Liu, Xuefeng Ai, K. C. Remant-Bahadur, Teo Atz Dick, Bingqian Yan, Tingting Lu, Xingliang Zhou, Runjiao Luo, Minglu Liu et al. · 2023 · Pharmaceutics
13. RNA Therapeutics: A Healthcare Paradigm Shift
    Sarfaraz K. Niazi · 2023 · Biomedicines
14. Aerosolized Non-viral Nucleic Acid Delivery in the Vaginal Tract of Pigs
    Katrien Remaut, Evelien De Clercq, Oliwia Andries, Koen Rombouts, Matthias Van Gils, Laetitia Cicchelero, Ian Vandenbussche, Sarah Van Praet, Juan Manuel Benito, José Manuel García Fernández et al. · 2015 · Pharmaceutical Research
15. Generation of Induced Pluripotent Stem Cells from Somatic Cells
    Young-Doug Sohn, Ji Woong Han, Young‐sup Yoon · 2012 · Progress in molecular biology and translational science
16. Site-Specific Covalent Conjugation of Modified mRNA by tRNA Guanine Transglycosylase
    Fabian Ehret, Cun Yu Zhou, Seth C. Alexander, Dongyang Zhang, Neal K. Devaraj · 2017 · Molecular Pharmaceutics
17. Current Status of Messenger RNA Delivery Systems
    Matthew G. Stanton · 2018 · Nucleic Acid Therapeutics
18. Nucleic acid therapies for cystic fibrosis
    Sasaki, Shruti, Guo, Shuling · 2018 · Nucleic Acid Therapeutics
19. Self-amplifying RNAs generated with the modified nucleotides 5-methylcytidine and 5-methyluridine mediate strong expression and immunogenicity in vivo
    Hiva Azizi, Tyler Milston Renner, Gerard Agbayani, Bryan Simard, Renu Dudani, Blair A. Harrison, Umar Iqbal, Yimei Jia, Michael J. McCluskie, Bassel Akache · 2024 · NAR Molecular Medicine
20. Transient pacing in pigs with complete heart block via myocardial injection of mRNA coding for the T-box transcription factor 18
    David W. Wolfson, Nam Kyun Kim, Ki Hong Lee, Jared P. Beyersdorf, Jonathan J. Langberg, Natasha Fernandez, Dahim Choi, Nadine Zureick, Tae Yun Kim, Seongho Bae et al. · 2024 · Nature Biomedical Engineering
21. Comparison of uridine and N1-methylpseudouridine mRNA platforms in development of an Andes virus vaccine
    Ivan V. Kuzmin, Rubén Soto-Acosta, Layne Pruitt, Perry T. Wasdin, Kritika Kedarinath, Keziah R. Hernandez, Kristyn A. Gonzales, Kharighan Hill, Nicole G. Weidner, Chad E. Mire et al. · 2024 · Nature Communications
22. Vaccine Strategies Against RNA Viruses: Current Advances and Future Directions
    Kuei Ching Hsiung, Huan-Jung Chiang, Sebastian Reinig, Shin‐Ru Shih · 2024 · Vaccines
23. Quantitative RNA pseudouridine maps reveal multilayered translation control through plant rRNA, tRNA and mRNA pseudouridylation
    Haoxuan Li, Guanqun Wang, Cheng‐Wei Ju, Zhongyu Zou, Bochen Jiang, Fan Yang, Kayla He, Cheng‐Wei Ju, Lisheng Zhang, Boyang Gao et al. · 2025 · Nature Plants
24. Monitoring mRNA vaccine antigen expression in vivo using PET/CT
    Gabrielle S. Blizard, Garima Dwivedi, Yi‐Gen Pan, Catherine Hou, Jean M. Etersque, Hooda Said, Anik Chevrier, Marc Lavertu, Houping Ni, Benjamin Davis et al. · 2025 · Nature Communications
25. Harnessing mRNA-lipid nanoparticles as innovative therapies for autoimmune diseases
    Rose Razavi, Michael Kegel, Jenna Muscat-Rivera, Drew Weissman, Jilian R. Melamed · 2025 · Molecular Therapy — Methods & Clinical Development
26. Strategies for modulating innate immune activation and protein production of in vitro transcribed mRNAs
    Kristin H. Loomis, Jonathan L. Kirschman, Sushma M. Bhosle, Ravi V. Bellamkonda, Philip J. Santangelo · 2015 · Journal of Materials Chemistry B
27. In the Era of mRNA Vaccines, Is There Any Hope for HIV Functional Cure?
    Ignasi Esteban, Carmen Pastor-Quiñones, Lorena Usero, Montserrat Plana, Felipe García, Lorna Leal · 2021 · Viruses
28. RNA in Cancer Immunotherapy: Unlocking the Potential of the Immune System
    Wout de Mey, Arthur Esprit, Kris Thielemans, Karine Breckpot, Lorenzo Franceschini · 2022 · Clinical Cancer Research
29. SINE RNA of the imprinted miRNA clusters mediates constitutive type III interferon expression and antiviral protection in hemochorial placentas
    Ishani Wickramage, Jeffrey VanWye, Klaas E.A. Max, John H. Lockhart, İsmet Hortu, Ezinne Francess Mong, John Canfield, Hiran Malinda Lamabadu Warnakulasuriya Patabendige, Ozlem Guzeloglu‐Kayisli, Kimiko Inoue et al. · 2023 · Cell Host & Microbe
30. Application of Lung-Targeted Lipid Nanoparticle-delivered mRNA of soluble PD-L1 via SORT Technology in Acute Respiratory Distress Syndrome
    Han Sun, Yu Zhang, Jiahui Wang, Juncheng Su, Dejian Zhou, Xiang Yu, Yingjie Xu, Wen Yang · 2023 · Theranostics
31. From rejection to the Nobel Prize: Karikó and Weissman’s pioneering work on mRNA vaccines, and the need for diversity and inclusion in translational immunology
    Amit Bansal · 2023 · Frontiers in Immunology
32. Cancer vaccines: from an immunology perspective
    Shania Makker, Charlotte Galley, Clare L. Bennett · 2023 · Immunotherapy Advances
33. Review: N1-methyl-pseudouridine (m1Ψ): Friend or foe of cancer?
    Alberto Rubio‐Casillas, David Cowley, Mikolaj Raszek, Vladimir Nikolaevich Uversky, Elrashdy M Moustafa Mohamed Redwan · 2024 · International Journal of Biological Macromolecules
34. Efficient Delivery and Functional Expression of Transfected Modified mRNA in Human Embryonic Stem Cell-derived Retinal Pigmented Epithelial Cells
    Magnus L. Hansson, Sílvia Albert, Louisa González Somermeyer, Rubén Peco, Eva Mejía-Ramírez, Núria Montserrat, Juan Carlos Izpisúa Belmonte · 2015 · Journal of Biological Chemistry
35. Pseudouridines or how to draw on weak energy differences
    Éric Westhof · 2019 · Biochemical and Biophysical Research Communications
36. From bench side to clinic: Potential and challenges of RNA vaccines and therapeutics in infectious diseases
    Pandey, Manish, Ojha, Divya, Bansal, Sakshi, Rode, Ambadas B., Chawla, Geetanjali · 2021 · Molecular Aspects of Medicine
37. Emerging Progress of RNA-Based Antitumor Therapeutics
    Jiayan Fu, Haiyang Dong, Jian Wu, Yongfeng Jin · 2023 · International Journal of Biological Sciences
38. mRNA Technology and Mucosal Immunization
    Antonio Toniolo, Giuseppe Maccari, Giovanni Camussi · 2024 · Vaccines
39. An efficient C-glycoside production platform enabled by rationally tuning the chemoselectivity of glycosyltransferases
    Min Li, Yang Zhou, Zexing Wen, Qian Ni, Ziqin Zhou, Yiling Liu, Qiang Zhou, Zongchao Jia, Bin Guo, Yuanhong Ma et al. · 2024 · Nature Communications
40. Distinct Inflammatory Programs Underlie the Intramuscular Lipid Nanoparticle Response
    William R. Dowell, Jacob S. Dearborn, Sylvester Languon, Zachary D. Miller, Tylar Kirch, Stephen Paige, Olivia Garvin, Lily Kjendal, Ethan Harby, Adam B. Zuchowski et al. · 2024 · The Journal of Immunology
41. Modulation of lipid nanoparticle-formulated plasmid DNA drives innate immune activation promoting adaptive immunity
    Nicholas J. Tursi, Sachchidanand Tiwari, Nicole M. Bedanova, Toshitha Kannan, Elizabeth M. Parzych, Nisreen M.A. Okba, Kevin Liaw, András Sárközy, Cory Livingston, Maria Ibanez Trullen et al. · 2025 · Cell Reports Medicine
42. Circular RNA lipid nanoparticle vaccine against SARS-CoV-2
    Kelsey L. Swingle, Alex G. Hamilton, Xuexiang Han, Kuo‐Chieh Liao, Hannah C. Safford, Ajay S. Thatte, Hannah C. Geisler, Junchao Xu, Tzuen Yih Saw, Yue Wan et al. · 2025 · Proceedings of the National Academy of Sciences
43. Computationally designed mRNA-launched protein nanoparticle immunogens elicit protective antibody and T cell responses in mice
    Grace G. Hendricks, Lilit Grigoryan, Mary Jane Navarro, Nicholas Catanzaro, Miranda L. Hubbard, John M. Powers, Melissa D. Mattocks, Catherine Treichel, Alexandra C. Walls, Jimin Lee et al. · 2025 · Science Translational Medicine
44. COVID-19: Current Developments and Further Opportunities in Drug Delivery and Therapeutics
    Saman Zafar, Muhammad Sohail Arshad, Sameen Fatima, Amna Alrasheed Abuzaid Ali, Aliyah Zaman, Elshaimaa Sayed, Ming‐Wei Chang, Zeeshan Ahmad · 2020 · Pharmaceutics
45. Development of an SS-Cleavable pH-Activated Lipid-Like Material (ssPalm) as a Nucleic Acid Delivery Device
    Hidetaka Akita · 2020 · Biological and Pharmaceutical Bulletin
46. Trigeminal and cervical radiculitis after tozinameran vaccination against COVID-19
    Kaavya Narasimhalu, Wai Ching Lee, Parag Ratnakar Salkade, Deidre Anne De Silva · 2021 · BMJ Case Reports
47. CRISPR-derived genome editing therapies: Progress from bench to bedside
    Holly A. Rees, Alex C. Minella, Cameron A. Burnett, Alexis C. Komor, Nicole M. Gaudelli · 2021 · Molecular Therapy
48. Chemically modified mRNA beyond COVID-19: Potential preventive and therapeutic applications for targeting chronic diseases
    Dana H. Elkhalifa, Menatallah Rayan, Ahmed T. Negmeldin, Abdelbary M. A. Elhissi, Ashraf A. Khalil · 2021 · Biomedicine & Pharmacotherapy
49. Microorganisms as Shapers of Human Civilization, from Pandemics to Even Our Genomes: Villains or Friends? A Historical Approach
    Francisco Rodríguez‐Frias, Josep Quer, David Tabernero, María Francesca Cortese, Selene García-García, Ariadna Rando‐Segura, Tomàs Pumarola · 2021 · Microorganisms
50. mRNA delivery technologies: Toward clinical translation
    Itziar Gómez-Aguado, Julen Rodríguez-Castejón, Marina Beraza-Millor, Alicia Rodríguez‐Gascón, Ana del Pozo‐Rodríguez, Maria Ángelés Solinís · 2022 · International review of cytology
51. Electrospun fiber-mediated delivery of neurotrophin-3 mRNA for neural tissue engineering applications
    Devan L. Puhl, Jessica L. Funnell, Tanner D. Fink, Anuj Swaminathan, Martin Oudega, R. Helen Zha, Ryan J. Gilbert · 2022 · Acta Biomaterialia
52. Lipid Microparticles Show Similar Efficacy With Lipid Nanoparticles in Delivering mRNA and Preventing Cancer
    Afang Ji, Minghao Xu, Yunzhi Pan, Lu Diao, Lin Ma, Qian Li, Junping Cheng, Mi Liu · 2022 · Pharmaceutical Research
53. Modified mRNA Therapeutics for Heart Diseases
    Ajit Magadum · 2022 · International Journal of Molecular Sciences
54. A nucleoside-modified mRNA vaccine forming rabies virus-like particle elicits strong cellular and humoral immune responses against rabies virus infection in mice
    Jie Liu, Jie Sun, Xue Ding, Wenhao Liu, Yipeng Wang, Zihan Wang, Hanyu Peng, Yong Zhang, Weiheng Su, Chunlai Jiang · 2024 · Emerging Microbes & Infections
55. Advancements in pseudouridine modifying enzyme and cancer
    Kaijie Liu, Shujun Zhang, Yafeng Liu, Xinjun Hu, Xinyu Gu · 2024 · Frontiers in Cell and Developmental Biology
56. STING‐Activating Polymers Boost Lymphatic Delivery of mRNA Vaccine to Potentiate Cancer Immunotherapy
    Miao Zhang, Yongling Wang, Benhao Li, Bowei Yang, Mengyao Zhao, Bingyu Li, Jianping Liu, Yaxin Hu, Zhaoming Wu, Yenhui Ong et al. · 2024 · Advanced Materials
57. RNA modifications in cancer
    Han Wu, Shi Chen, Xiang Li, Yuyang Li, He Shi, Yiwen Qin, Bin Shi, Yifei Tang, Zhuoyi Yan, Yang Hao et al. · 2025 · MedComm
58. The kinetics of endosomal disruption reveal differences in lipid nanoparticle induced cellular toxicity
    Stephanie M. Bates, Michael J. Munson, Vítor Trovisco, Sara G. T. Pereira, Sophie R. Miller, Alan Sabirsh, Catherine Jean Betts, Erik Oude Blenke, Nicholas J. Gay · 2025 · Journal of Controlled Release
59. mRNA vaccines: immunogenicity and quality characteristics
    Yaru Quan, Huijie Yang, Weini Li, Linxian X. Li · 2025 · Journal of Nanobiotechnology
60. Co-Delivery of mRNA and pDNA Using Thermally Stabilized Coacervate-Based Core-Shell Nanosystems
    Sarah S. Nasr, Sangeun Lee, Durairaj Thiyagarajan, Annette S. Boese, Brigitta Loretz, Claus‐Michael Lehr · 2021 · Pharmaceutics
61. Noncoding snoRNA host genes are a distinct subclass of long noncoding RNAs
    Alan Monziani, Igor Ulitsky · 2023 · Trends in Genetics
62. RNA nanostructures for targeted drug delivery and imaging
    Laura Teodori, Marjan Omer, Jørgen Kjems · 2024 · RNA Biology
63. mRNA-transfected Dendritic Cells Expressing Polypeptides That Link MHC-I Presentation to Constitutive TLR4 Activation Confer Tumor Immunity
    Gal Cafri, Adi Sharbi‐Yunger, Esther Tzehoval, Zoya Alteber, Tamar Gross, Ezra Vadai, Alon Margalit, Gideon Gross, Lea Eisenbach · 2015 · Molecular Therapy
64. Incorporation of 5 methylcytidine alleviates innate immune response to self-amplifying RNA vaccine
    Komori, Mai, Morey, Amber L., Quiñones-Molina, Andrés A., Fofana, Josiane, Romero, Luis, Peters, Elizabeth, Matsuda, Kenta, Gummuluru, Suryaram, Smith, Jonathan F., Akahata, Wataru et al. · 2023
65. mRNA medicine: Recent progresses in chemical modification, design, and engineering
    Xiaowen Hou, Jinjun Shi, Yuling Xiao · 2024 · Nano Research
66. Optimizing mRNA translation efficiency through rational 5′UTR and 3′UTR combinatorial design
    Ting Li, Gang‐Feng Liu, Guo‐Long Bu, Yuan Xu, Caiyun He, Gexin Zhao · 2025 · Gene
67. The mRNA component of LNP-mRNA vaccines triggers IFNAR-dependent immune activation which attenuates the adaptive immune response
    Liat Bar‐On, Hila Cohen, Uri Elia, Lilach Cherry, Ofer Cohen, Noam Erez A · 2025 · Frontiers in Immunology
68. Systematic evaluation of computational tools for multitype RNA modification detection using nanopore direct RNA sequencing
    Tingting Luo, Moping Xu, Miao Wang, Faying Chen, Jiejun Shi · 2025 · Nature Methods
69. Material Design for Next-Generation mRNA Vaccines Using Lipid Nanoparticles
    Akon Higuchi, Tzu‐Cheng Sung, Ting Wang, Qing‐Dong Ling, Suresh S. Kumar, Shih-Tien Hsu, Akihiro Umezawa · 2022 · Journal of macromolecular science. Part C, Reviews in macromolecular chemistry and physics/Journal of macromolecular science. Reviews in macromolecular chemistry and physics
70. Lipid‐based nucleic acid therapeutics with in vivo efficacy
    Md Abu Sufian, Marc Antoniu Ilies · 2022 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
71. Structural basis of transcription recognition of a hydrophobic unnatural base pair by T7 RNA polymerase
    Juntaek Oh, Michiko Kimoto, Haoqing Xu, Jenny P C Chong, Ichiro Hirao, Dong Wang · 2023 · Nature Communications
72. mRNA Vaccine - A New Cancer Treatment Strategy
    Tian Tan, Shuting Deng, Bing-Huo Wu, Qi Yang, Mengwan Wu, Hong Wu, Chenhui Cao, Chuan Shan Xu · 2023 · Current Cancer Drug Targets
73. The clinical progress and challenges of mRNA vaccines
    Meng‐Zhen Yu, Nannan Wang, Jia‐Qing Zhu, Yao‐Xin Lin · 2023 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
74. Addressing the in vivo delivery of nucleic-acid nanostructure therapeutics
    Shana Alexander, Mohammadamir G. Moghadam, Meghan Rothenbroker, Leo Y. T. Chou · 2023 · Advanced Drug Delivery Reviews
75. Exploring HIV Vaccine Progress in the Pre-Clinical and Clinical Setting: From History to Future Prospects
    Amitinder Kaur, Monica Vaccari · 2024 · Viruses
76. Comprehensive evaluation of T7 promoter for enhanced yield and quality in mRNA production
    Yustika Sari, Sara Sousa Rosa, Jack W. E. Jeffries, Marco P. C. Marques · 2024 · Scientific Reports
77. iPS cell therapy 2.0: Preparing for next‐generation regenerative medicine
    Kelvin K. Hui, Shinya Yamanaka · 2024 · BioEssays
78. Chemical Probe-Based Nanopore Sequencing to Selectively Assess the RNA Modifications
    Soundhar Ramasamy, Vinodh J Sahayasheela, Surbhi Sharma, Zutao Yu, Takuya Hidaka, Li Cai, Thangavel Vaijayanthi, Hiroshi Sugiyama, Ganesh N. Pandian · 2022 · ACS Chemical Biology
79. Approaches to Enhance the Potency of Vaccines in Chickens
    Oenone Bodman-Harris, Christine S. Rollier, Munir Iqbal · 2024 · Vaccines
80. Current Trends in Messenger RNA Technology for Cancer Therapeutics
    Ali Afzal, Muddasir Hassan Abbasi, Shaaf Ahmad, Nadeem Sheikh, Muhammad Babar Khawar · 2025 · Biomaterials Research
81. RNA stability enhancers for durable base-modified mRNA therapeutics
    Jung, Soo-Jin, Seo, Jenny J., Lee, Sunghan, Hyun, Seong-In, Lee, Ji-eun, Lee, Sojeong, Lee, Yeji, Chang, Hyeshik, Lee, Hyukjin, Kim, Jin-Hong et al. · 2025 · Nature Biotechnology
82. Efficient reduction of synthetic mRNA induced immune activation by simultaneous delivery of B18R encoding mRNA
    Tatjana Michel, Sonia Golombek, Heidrun Steinle, Ludmilla Hann, Ana Velić, Boris Maček, Stefanie Krajewski, Christian Schlensak, Hans Peter Wendel, Meltem Avci‐Adali · 2019 · Journal of Biological Engineering
83. Early approval of COVID-19 vaccines: Pros and cons
    Md Arifur Rahman, Md Sayeedul Islam · 2021 · Human Vaccines & Immunotherapeutics
84. The mRNA vaccine revolution is the dividend from decades of basic science research
    Arturo Casadevall · 2021 · Journal of Clinical Investigation
85. The Potential of Nanomedicine to Unlock the Limitless Applications of mRNA
    Laura Taina-González, María de la Fuente · 2022 · Pharmaceutics
86. Synthetic RNA-based post-transcriptional expression control methods and genetic circuits
    Malvin Leonardo Pardi, Juanqi Wu, Shunsuke Kawasaki, Hirohide Saito · 2022 · Advanced Drug Delivery Reviews
87. mRNA-based therapies: Preclinical and clinical applications
    Musga Qureischi, Julia Mohr, Estibaliz Arellano-Viera, Sarah E. Knudsen, Farrukh Vohidov, Andoni Garitano-Trojaola · 2022 · International review of cytology
88. Immune responses related to the immunogenicity and reactogenicity of COVID-19 mRNA vaccines
    Takayuki Matsumura, Tomohiro Takano, Yoshimasa Takahashi · 2022 · International Immunology
89. Screening of Tumor Antigens and Construction of Immune Subtypes for mRNA Vaccine Development in Head and Neck Squamous Cell Carcinoma
    Hongxia Li, Tianrun Liu, Zhaoxu Tu, Chubo Xie, Weiping Wen, Wei Sun · 2022 · Biomolecules
90. RNA nanomedicine in liver diseases
    Anita K. Bakrania, Yulin Mo, Gang Zheng, Mamatha Bhat · 2023 · Hepatology
91. The Effect of Cholesterol Content on the Adjuvant Activity of Nucleic-Acid-Free Lipid Nanoparticles
    Jessica Anindita, Hiroki Tanaka, Takuma Yamakawa, Yuka Sato, Chika Matsumoto, Kota Ishizaki, Taiji Oyama, Satoko Suzuki, Keisuke Ueda, Kenjirou Higashi et al. · 2024 · Pharmaceutics
92. Co-delivery of Cas9 mRNA and guide RNAs for editing of LGMN gene represses breast cancer cell metastasis
    Yue Wang, Yatu Peng, Guanghui Zi, Jin Chen, Baowei Peng · 2024 · Scientific Reports
93. An Efficient Protection-Free One-Pot Chemical Synthesis of Modified Nucleoside-5′-Triphosphates
    Muthian Shanmugasundaram, Annamalai Senthilvelan, Zejun Xiao, Anilkumar R. Kore · 2016 · Nucleosides Nucleotides & Nucleic Acids
94. Infectious RNA vaccine protects mice against chikungunya virus infection
    Inga Szurgot, Karl Ljungberg, Beate Mareike Kümmerer, Peter Liljeström · 2020 · Scientific Reports
95. A prion accelerates proliferation at the expense of lifespan
    David M. Garcia, E. Campbell, Christopher M. Jakobson, Mitsuhiro Tsuchiya, Ethan A. Shaw (23811802), Acadia L. DiNardo, Matt R. Kaeberlein, Daniel F. Jarosz · 2021 · eLife
96. Light‐Activated Control of Translation by Enzymatic Covalent mRNA Labeling
    Dongyang Zhang, Cun Yu Zhou, Kayla N. Busby, Seth C. Alexander, Neal K. Devaraj · 2018 · Angewandte Chemie
97. Current Challenges in Nucleic Acid Synthesis
    Richard I. Hogrefe, Brea Midthune, Alexandre V. Lebedev · 2013 · Israel Journal of Chemistry
98. Nucleofection induces transient eIF2α phosphorylation by GCN2 and PERK
    Bart R. Anderson, Katalin Karikó, Drew Weissman · 2012 · Gene Therapy
99. Towards clinical translation of nanomedicines: Formulation scale-up and model systems
    Owen M. Kelly, Andrew R. Hanna, Addison K. Byrne, Jonathan A. Green, Iuri Viótti Périssé, Kevin Dale Wells, Stephen A. Murray, Jie Xu, Y. Eugene Chen, Irina A. Polejaeva et al. · 2026 · Advanced Drug Delivery Reviews
100. Hydrophobic Optimization of Functional Poly(TPAE-co-suberoyl chloride) for Extrahepatic mRNA Delivery following Intravenous Administration
     Xueliang Yu, Shuai Liu, Qiang Cheng, Sang M. Lee, Tuo Wei, Di Zhang, Lukas Farbiak, Lindsay T. Johnson, Xu Wang, Daniel J. Siegwart · 2021 · Pharmaceutics